C. Bibliographiques-abbott and D. Chambers, Analysis of CAG trinucleotide repeats from mouse cDNA sequences, Annals of Human Genetics, vol.266, issue.2, pp.87-94, 1994.
DOI : 10.1016/0888-7543(90)90195-Z

K. -afshar, J. Scholey, and R. Hawley, Identification of the chromosome localization domain of the Drosophila nod kinesin-like protein, The Journal of Cell Biology, vol.131, issue.4, pp.833-876, 1995.
DOI : 10.1083/jcb.131.4.833

A. Ahmed, R. Schmidt, C. H. Park, N. Reed, S. Hesse et al., Effect of Disrupting Seven-in-Absentia Homolog 2 Function on Lung Cancer Cell Growth, JNCI: Journal of the National Cancer Institute, vol.171, issue.7, pp.1606-1635, 2008.
DOI : 10.4049/jimmunol.171.7.3768

B. Bae, M. Hara, M. Cascio, C. Wellington, M. Hayden et al., Mutant Huntingtin: Nuclear translocation and cytotoxicity mediated by GAPDH, Proceedings of the National Academy of Sciences, vol.96, issue.24, pp.3405-3414, 2006.
DOI : 10.1073/pnas.96.24.13978

URL : http://www.pnas.org/content/103/9/3405.full.pdf

R. Bai, V. Staedtke, and G. Riggins, Molecular targeting of glioblastoma: Drug discovery and therapies, Trends in Molecular Medicine, vol.17, issue.6, pp.301-313, 2011.
DOI : 10.1016/j.molmed.2011.01.011

I. Baldi, A. Huchet, L. Bauchet, and H. Loiseau, ??pid??miologie des glioblastomes, Neurochirurgie, vol.56, issue.6, pp.433-440, 2010.
DOI : 10.1016/j.neuchi.2010.07.011

M. Bani, J. Rak, D. Adachi, R. Wiltshire, J. Trent et al., Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype, Cancer Res, vol.56, pp.3075-86, 1996.

Y. Barak, D. Liao, W. He, E. Ong, M. Nelson et al., Effects of peroxisome proliferator-activated receptor ?? on placentation, adiposity, and colorectal cancer, Proceedings of the National Academy of Sciences, vol.473, issue.3, pp.303-311, 2002.
DOI : 10.1016/S0014-5793(00)01554-4

E. Barroso, X. Eyre, . Palomer, and M. Vázquez-carrera, The peroxisome proliferator-activated receptor ??/?? (PPAR??/??) agonist GW501516 prevents TNF-??-induced NF-??B activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1, Biochemical Pharmacology, vol.81, issue.4, pp.534-543, 2011.
DOI : 10.1016/j.bcp.2010.12.004

A. -behin, K. Hoang-xuan, A. F. Carpentier, and J. Y. Delattre, Primary brain tumours in adults, The Lancet, vol.361, issue.9354, pp.323-331, 2003.
DOI : 10.1016/S0140-6736(03)12328-8

K. Berge, K. Tronstad, E. Flindt, T. Rasmussen, L. Madsen et al., Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways, Carcinogenesis, vol.22, issue.11, pp.1747-55, 2001.
DOI : 10.1016/S0021-9150(99)00329-9

C. Blanquart, O. Barbier, J. Fruchart, B. Staels, and C. Glineur, Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation, The Journal of Steroid Biochemistry and Molecular Biology, vol.85, issue.2-5, pp.267-73, 2003.
DOI : 10.1016/S0960-0760(03)00214-0

S. -bogdan, S. Senkel, F. Esser, G. Ryffel, P. Strandmann et al., Misexpression of Xsiah-2 induces a small eye phenotype in Xenopus, Mechanisms of Development, vol.103, issue.1-2, pp.61-70, 2001.
DOI : 10.1016/S0925-4773(01)00332-X

K. Borden and P. Freemont, The RING finger domain: a recent example of a sequence???structure family, Current Opinion in Structural Biology, vol.6, issue.3, pp.395-401, 1996.
DOI : 10.1016/S0959-440X(96)80060-1

M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Analytical Biochemistry, vol.72, issue.1-2, pp.248-54, 1976.
DOI : 10.1016/0003-2697(76)90527-3

A. Brauckhoff, M. Malz, D. Tschaharganeh, N. Malek, A. Weber et al., Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells, Journal of Hepatology, vol.55, issue.5, pp.1049-57, 2011.
DOI : 10.1016/j.jhep.2011.02.019

N. -brugière, S. Rothstein, and Y. Cui, Molecular mechanisms of self-recognition in Brassica self-incompatibility, Trends in Plant Science, vol.5, issue.10, pp.432-440, 2000.
DOI : 10.1016/S1360-1385(00)01759-3

H. -bruzzoni-giovanelli, A. Faille, G. Linares-cruz, M. Nemani, L. Deist et al., SIAH-1 inhibits cell growth by altering the mitotic process, Oncogene, vol.18, issue.50, pp.7101-7110, 1999.
DOI : 10.1016/S0092-8674(00)80506-1

M. -calzado, L. Vega, E. Munoz, and M. Schmitz, Autoregulatory control of the p53 response by Siah-1L-mediated HIPK2 degradation, Biological Chemistry, vol.390, issue.10, pp.1079-83, 2009.
DOI : 10.1515/BC.2009.112

P. -carthew and A. Smith, Pathological mechanisms of hepatic tumour formation in rats exposed chronically to dietary hexachlorobenzene, Journal of Applied Toxicology, vol.7, issue.6, pp.447-52, 1994.
DOI : 10.1038/bjc.1956.15

R. Carthew and G. Rubin, seven in absentia, a gene required for specification of R7 cell fate in the Drosophila eye, Cell, vol.63, issue.3, pp.561-577, 1990.
DOI : 10.1016/0092-8674(90)90452-K

P. -chan, A. Moller, M. Liu, J. Sceneay, C. Wong et al., The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression, Breast Cancer Research, vol.22, issue.1, p.19, 2011.
DOI : 10.1111/j.1755-148X.2009.00628.x

P. Chui, H. Guan, M. Lehrke, and M. Lazar, PPAR?? regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1, Journal of Clinical Investigation, vol.115, issue.8, pp.2244-56, 2005.
DOI : 10.1172/JCI24130

URL : http://www.jci.org/articles/view/24130/files/pdf

A. -ciechanover, The ubiquitin-proteasome pathway: on protein death and cell life, The EMBO Journal, vol.17, issue.24, 1998.
DOI : 10.1093/emboj/17.24.7151

A. -ciechanover and A. Schwartz, The ubiquitin-proteasome pathway: The complexity and myriad functions of proteins death, Proceedings of the National Academy of Sciences, vol.86, issue.2, pp.2727-2757, 1998.
DOI : 10.1016/S0092-8674(00)80097-5

Y. -cui, Y. Bi, N. Brugière, M. Arnoldo, and S. Rothstein, The S locus glycoprotein and the S receptor kinase are sufficient for self-pollen rejection in Brassica, Proceedings of the National Academy of Sciences, vol.286, issue.5445, pp.3713-3720, 2000.
DOI : 10.1126/science.286.5445.1697

C. -de-duve, The Peroxisome: A New Cytoplasmic Organelle, Proceedings of the Royal Society B: Biological Sciences, vol.173, issue.1030, pp.71-83, 1969.
DOI : 10.1098/rspb.1969.0039

N. Della, P. Senior, and D. Bowtell, Isolation and characterisation of murine homologues of the Drosophila seven in absentia gene (sina), Development, vol.117, pp.1333-1376, 1993.

-. , N. Tan, N. Michalik, L. Wahli, W. Desvergne et al., Antiapoptotic role of {PPARbeta} in keratinocytes via transcriptional control of the Akt1 signaling pathway, Mol Cell, vol.10, pp.721-733, 2002.

M. -fantappie, A. Osman, C. Ericsson, E. Niles, and P. Loverde, Cloning of Schistosoma mansoni Seven in Absentia (SmSINA)+ homologue cDNA, a gene involved in ubiquitination of SmRXR1 and SmRXR2*1, Molecular and Biochemical Parasitology, vol.131, issue.1, 2003.
DOI : 10.1016/S0166-6851(03)00188-9

J. -feige, L. Gelman, C. Tudor, Y. Engelborghs, W. Wahli et al., Fluorescence Imaging Reveals the Nuclear Behavior of Peroxisome Proliferator-activated Receptor/Retinoid X Receptor Heterodimers in the Absence and Presence of Ligand, Journal of Biological Chemistry, vol.35, issue.18, pp.17880-90, 2005.
DOI : 10.1128/MCB.24.14.6393-6402.2004

G. -fiucci, S. Beaucourt, D. Duflaut, A. Lespagnol, P. Stumptner-cuvelette et al., Siah-1b is a direct transcriptional target of p53: Identification of the functional p53 responsive element in the siah-1b promoter, Proceedings of the National Academy of Sciences, vol.512, issue.1-3, pp.3510-3515, 2004.
DOI : 10.1016/S0014-5793(02)02265-2

J. Foreman, W. Chang, P. Palkar, B. Zhu, M. Borland et al., Functional characterization of peroxisome proliferatoractivated receptor-?/? expression in colon cancer. Mol Carcinogen, pp.884-900, 2011.

J. Foreman, J. Sorg, K. Mcginnis, B. Rigas, J. Williams et al., Regulation of peroxisome proliferator-activated receptor-??/?? by the APC/??-CATENIN pathway and nonsteroidal antiinflammatory drugs, Molecular Carcinogenesis, vol.52, issue.10, pp.942-952, 2009.
DOI : 10.1002/mc.20546

J. -frasor, J. Danes, C. Funk, and B. Katzenellenbogen, Estrogen down-regulation of the corepressor N-CoR: Mechanism and implications for estrogen derepression of N-CoR-regulated genes, Proceedings of the National Academy of Sciences, vol.11, issue.6, pp.13153-13160, 2005.
DOI : 10.1210/me.11.6.657

I. Frew, V. Hammond, R. Dickins, J. Quinn, and C. Walkley, Generation and Analysis of Siah2 Mutant Mice, Molecular and Cellular Biology, vol.23, issue.24, pp.9150-61, 2003.
DOI : 10.1128/MCB.23.24.9150-9161.2003

I. Frew, R. Dickins, A. Cuddihy, D. Rosario, M. Reinhard et al., Normal p53 Function in Primary Cells Deficient for Siah Genes, Molecular and Cellular Biology, vol.22, issue.23, pp.8155-64, 2002.
DOI : 10.1128/MCB.22.23.8155-8164.2002

I. Frew, N. Sims, J. Quinn, C. Walkley, L. Purton et al., Mutant Mice, Journal of Biological Chemistry, vol.105, issue.28, pp.29583-29591, 2004.
DOI : 10.1016/S0092-8674(02)01049-8

S. Han, J. Ritzenthaler, B. Wingerd, and J. Roman, Receptor Subtype EP4, Journal of Biological Chemistry, vol.62, issue.39, pp.33240-33249, 2005.
DOI : 10.1016/S0014-4827(03)00269-6

M. Hara, N. Agrawal, S. Kim, M. Cascio, M. Fujimuro et al., S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding, Nature Cell Biology, vol.92, issue.7, pp.665-674, 2005.
DOI : 10.1073/pnas.92.16.7162

Y. Hatano, M. Man, Y. Uchida, D. Crumrine, T. Mauro et al., Murine atopic dermatitis responds to peroxisome proliferator-activated receptors ?? and ??/?? (but not ??) and liver X receptor activators, Journal of Allergy and Clinical Immunology, vol.125, issue.1, pp.160-169, 2010.
DOI : 10.1016/j.jaci.2009.06.049

H. -he, E. Fokas, A. You, R. Engenhart-cabillic, and H. An, Siah1 proteins enhance radiosensitivity of human breast cancer cells, BMC Cancer, vol.160, issue.3, p.403, 2010.
DOI : 10.1667/RR3043

P. -he, M. Borland, B. Zhu, A. Sharma, S. Amin et al., Effect of ligand activation of peroxisome proliferator-activated receptor-??/?? (PPAR??/??) in human lung cancer cell lines, Toxicology, vol.254, issue.1-2, pp.112-117, 2008.
DOI : 10.1016/j.tox.2008.09.023

T. -he, T. Chan, B. Vogelstein, and K. Kinzler, PPAR?? Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs, Cell, vol.99, issue.3, pp.335-380, 1999.
DOI : 10.1016/S0092-8674(00)81664-5

A. Helseth, The incidence of primary CNS neoplasms before and after computerized tomography availability, Journal of Neurosurgery, vol.3, issue.6, pp.999-1003, 1995.
DOI : 10.1093/ije/16.2.177

-. Lhofmann, T. Moller, A. Sirma, H. Zentgraf, H. Taya et al., A new ticket for entry into budding vesicles-ubiquitin Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2, Cell. Nat Cell Biol, vol.106, issue.4, pp.527-557, 2001.

T. Hofmann and M. Schmitz, The promoter context determines mutual repression or synergism between NF-kappaB and the glucocorticoid receptor, Biol Chem, vol.383, pp.1947-51, 2002.

H. Hollingshead, R. Killins, M. Borland, E. Girroir, A. Billin et al., Peroxisome proliferator-activated receptor-??/?? (PPAR??/??) ligands do not potentiate growth of human cancer cell lines, Carcinogenesis, vol.6, issue.12, pp.2641-2650, 2007.
DOI : 10.4161/cc.6.6.4030

A. Holloway, N. Della, and C. Fletcher, Chromosomal Mapping of Five Highly Conserved Murine Homologues of theDrosophilaRING Finger GeneSeven-in-absentia, Genomics, vol.41, issue.2, pp.160-80, 1997.
DOI : 10.1006/geno.1997.4642

A. -hörlein, A. Näär, T. Heinzel, J. Torchia, B. Gloss et al., Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor, Nature, vol.377, issue.6548, pp.397-404, 1995.
DOI : 10.1038/377397a0

C. House, I. Frew, H. Huang, G. Wiche, N. Traficante et al., A binding motif for Siah ubiquitin ligase, Proceedings of the National Academy of Sciences, vol.22, issue.19, pp.3101-3107, 2003.
DOI : 10.1128/MCB.22.19.6854-6865.2002

G. Hu and E. Fearon, Siah-1 N-Terminal RING Domain Is Required for Proteolysis Function, and C-Terminal Sequences Regulate Oligomerization and Binding to Target Proteins, Molecular and Cellular Biology, vol.19, issue.1, pp.724-756, 1999.
DOI : 10.1128/MCB.19.1.724

G. Hu, S. Zhang, M. Vidal, J. Baer, T. Xu et al., Mammalian homologs of seven in absentia regulate DCC via the ubiquitin-proteasome??pathway, Genes & Development, vol.11, issue.20, pp.2701-2714, 1997.
DOI : 10.1101/gad.11.20.2701

A. -ijpenberg, E. Jeannin, W. Wahli, and B. Desvergne, Polarity and Specific Sequence Requirements of Peroxisome Proliferator-activated Receptor (PPAR)/Retinoid X Receptor Heterodimer Binding to DNA, Journal of Biological Chemistry, vol.348, issue.32, pp.20108-20125, 1997.
DOI : 10.1126/science.2115209

I. -issemann and S. Green, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature, vol.347, issue.6294, pp.645-50, 1990.
DOI : 10.1038/347645a0

A. -iwai, H. Marusawa, S. Matsuzawa, T. Fukushima, M. Hijikata et al., Siah-1L, a novel transcript variant belonging to the human Siah family of proteins, regulates ??-catenin activity in a p53-dependent manner, Oncogene, vol.23, issue.45, pp.7593-7600, 2004.
DOI : 10.1006/bbrc.2001.4788

T. Jung, Y. Choi, Y. Kim, J. Lee, H. Kim et al., Immunological characterization of glioblastoma cells for immunotherapy, Anticancer Res, vol.33, pp.2525-2558, 2013.

C. Kim, Y. Cho, C. Park, S. Jeong, S. Nam et al., Inactivating mutations of the Siah-1 gene in gastric cancer, Oncogene, vol.23, issue.53, pp.8591-8597, 2004.
DOI : 10.1073/pnas.96.14.8070

-. , S. Choi, D. Kim, E. Choi, and C. , Stabilization of HIPK2 by escape from proteasomal degradation mediated by the E3 ubiquitin ligase Siah1, Cancer Lett, vol.279, pp.177-84, 2009.

M. Li, G. Pascual, and C. Glass, Peroxisome Proliferator-Activated Receptor gamma -Dependent Repression of the Inducible Nitric Oxide Synthase Gene, Molecular and Cellular Biology, vol.20, issue.13, pp.4699-707, 2000.
DOI : 10.1128/MCB.20.13.4699-4707.2000

S. Li, N. Ting, L. Zheng, P. Chen, Y. Ziv et al., Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response, Nature, vol.273, issue.6792, pp.210-215, 2000.
DOI : 10.1074/jbc.273.11.6183

E. -liani, A. Eyal, E. Avraham, R. Shemer, R. Szargel et al., Ubiquitylation of synphilin-1 and ??-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease, Proceedings of the National Academy of Sciences, vol.278, issue.51, pp.5500-5505, 2004.
DOI : 10.1074/jbc.M306347200

E. -linos, T. Raine, A. Alonso, and D. Michaud, Atopy and Risk of Brain Tumors: A Meta-analysis, JNCI Journal of the National Cancer Institute, vol.107, issue.1, pp.1544-50, 2007.
DOI : 10.1046/j.1365-2567.2002.01507.x

J. Liu, J. Stevens, C. Rote, H. Yost, Y. Hu et al., Siah-1 Mediates a Novel ??-Catenin Degradation Pathway Linking p53 to the Adenomatous Polyposis Coli Protein, Molecular Cell, vol.7, issue.5, pp.927-963, 2001.
DOI : 10.1016/S1097-2765(01)00241-6

K. Lorick, J. Jensen, S. Fang, A. Ong, S. Hatakeyama et al., RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination, Proceedings of the National Academy of Sciences, vol.273, issue.14, pp.11364-11373, 1999.
DOI : 10.1074/jbc.273.14.7795

D. Louis, H. Ohgaki, O. Wiestler, W. Cavenee, P. Burger et al., The 2007 WHO classification of tumours of the central nervous system, 2007.

J. -lüders, J. Demand, and J. Höhfeld, The Ubiquitin-related BAG-1 Provides a Link between the Molecular Chaperones Hsc70/Hsp70 and the Proteasome, Journal of Biological Chemistry, vol.13, issue.7, pp.4613-4620, 2000.
DOI : 10.1016/S0962-8924(99)01580-9

E. Maher, F. Furnari, R. Bachoo, D. Rowitch, D. Louis et al., Malignant glioma: genetics and biology of a grave matter, Genes & Development, vol.15, issue.11, pp.1311-1344, 2001.
DOI : 10.1101/gad.891601

B. -mandon-pépin, A. Oustry-vaiman, B. Vigier, F. Piumi, E. Cribiu et al., Expression Profiles and Chromosomal Localization of Genes Controlling Meiosis and Follicular Development in the Sheep Ovary1, Biology of Reproduction, vol.116, issue.3, pp.985-95, 2003.
DOI : 10.1530/jrf.0.1160277

-. , J. Alizadeh, A. Segraves, R. Blesa, D. Rubio-moscardo et al., Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations, Blood, vol.101, pp.3109-3126, 2003.

S. Matsuzawa, S. Takayama, B. Froesch, J. Zapata, and J. Reed, p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1, The EMBO Journal, vol.17, issue.10, 1998.
DOI : 10.1093/emboj/17.10.2736

S. Matsuzawa and J. Reed, Siah-1, SIP, and Ebi Collaborate in a Novel Pathway for ??-Catenin Degradation Linked to p53 Responses, Molecular Cell, vol.7, issue.5, pp.915-941, 2001.
DOI : 10.1016/S1097-2765(01)00242-8

B. Mckinley, A. Michalek, R. Fenstermaker, and R. Plunkett, The impact of age and gender on the incidence of glial tumors in New York state from 1976???1995, Journal of Neurosurgery, vol.17, issue.6, pp.932-971, 2000.
DOI : 10.1007/BF01054274

L. -michalik, B. Desvergne, and W. Wahli, Peroxisome-proliferator-activated receptors and cancers: complex stories, Nature Reviews Cancer, vol.63, issue.1, pp.61-70, 2004.
DOI : 10.1172/JCI1235

A. -möller, C. House, C. Wong, D. Scanlon, M. Liu et al., Inhibition of Siah ubiquitin ligase function, Oncogene, vol.12, issue.2, pp.289-96, 2009.
DOI : 10.1152/physrev.00027.2001

S. Moreno, S. Farioli-vecchioli, and M. Ceru, Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS, Neuroscience, vol.123, issue.1, pp.131-176, 2004.
DOI : 10.1016/j.neuroscience.2003.08.064

R. Nadeau, J. Toher, X. Yang, D. Kovalenko, and R. Friesel, Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2, Journal of Cellular Biochemistry, vol.109, issue.1, pp.151-60, 2007.
DOI : 10.1128/MCB.19.1.724

Y. -nagano, T. Fukushima, K. Okemoto, K. Tanaka, D. Bowtell et al., stability and cell migration under metabolic stress, Cell Cycle, vol.1, issue.15, pp.2592-2602, 2011.
DOI : 10.1126/science.1092053

M. Nakamura, Y. Yonekawa, P. Kleihues, and H. Ohgaki, Promoter Hypermethylation of the RB1 Gene in Glioblastomas, Laboratory Investigation, vol.54, issue.1, pp.77-82, 2001.
DOI : 10.1093/jnci/86.9.695

T. Nakamura, T. Funahashi, S. Yamashita, M. Nishida, and Y. Nishida, Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation???double-blind placebo-controlled trial, Diabetes Research and Clinical Practice, vol.54, issue.3, pp.181-90, 2001.
DOI : 10.1016/S0168-8227(01)00319-9

T. Nakamura, Y. Tsubono, K. Kameda-takemura, T. Funahashi, S. Yamashita et al., Magnitude of Sustained Multiple Risk Factors for Ischemic Heart Disease in Japanese Employees, Japanese Circulation Journal, vol.65, issue.1, pp.11-18, 2001.
DOI : 10.1253/jcj.65.11

K. -nakayama, I. Frew, M. Hagensen, M. Skals, H. Habelhah et al., Siah2 Regulates Stability of Prolyl-Hydroxylases, Controls HIF1?? Abundance, and Modulates Physiological Responses to Hypoxia, Cell, vol.117, issue.7, pp.941-52, 2004.
DOI : 10.1016/j.cell.2004.06.001

K. -nakayama and Z. Ronai, Siah: New Players in the Cellular Response to Hypoxia, Cell Cycle, vol.3, issue.11, pp.1345-1352, 2004.
DOI : 10.4161/cc.3.11.1207

P. Nambiar, C. Giardina, K. Guda, W. Aizu, R. Raja et al., Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model, Cancer Res, vol.62, pp.3667-74, 2002.

P. -neiman, A. Ruddell, C. Jasoni, G. Loring, S. Thomas et al., Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius, Proceedings of the National Academy of Sciences, vol.1, issue.8, pp.6378-83, 2001.
DOI : 10.1038/70237

M. -nemani, G. Linares-cruz, H. Bruzzoni-giovanelli, J. Roperch, and M. Tuynder, Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression., Proceedings of the National Academy of Sciences, vol.93, issue.17, pp.9039-9081, 1996.
DOI : 10.1073/pnas.93.17.9039

H. -ohgaki and P. Kleihues, Population-Based Studies on Incidence, Survival Rates, and Genetic Alterations in Astrocytic and Oligodendroglial Gliomas, Journal of Neuropathology & Experimental Neurology, vol.10, issue.6, pp.479-489, 2005.
DOI : 10.1093/carcin/16.6.1277

W. Oliver, J. Shenk, M. Snaith, C. Russell, K. Plunket et al., A selective peroxisome proliferator-activated receptor ?? agonist promotes reverse cholesterol transport, Proceedings of the National Academy of Sciences, vol.42, issue.19, pp.5306-5317, 2001.
DOI : 10.1021/jm9903601

A. Omuro and L. Deangelis, Glioblastoma and Other Malignant Gliomas, JAMA, vol.310, issue.17, pp.1842-50, 2013.
DOI : 10.1001/jama.2013.280319

C. Palmer, M. Hsu, K. Griffin, and E. Johnson, Novel Sequence Determinants in Peroxisome Proliferator Signaling, Journal of Biological Chemistry, vol.13, issue.27, pp.16114-16135, 1995.
DOI : 10.1006/bbrc.1993.1378

A. -papi, P. Rocchi, A. Ferreri, F. Guerra, and M. Orlandi, Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells, Oncol Rep, vol.21, pp.1083-1092, 2009.

A. -papi, L. Tatenhorst, D. Terwel, M. Hermes, M. Kummer et al., glioma models, Journal of Neurochemistry, vol.37, issue.6, pp.1779-1790, 2009.
DOI : 10.1016/j.febslet.2007.11.081

B. Park, B. Vogelstein, and K. Kinzler, Genetic disruption of PPAR?? decreases the tumorigenicity of human colon cancer cells, Proceedings of the National Academy of Sciences, vol.260, issue.5104, pp.2598-2603, 2001.
DOI : 10.1126/science.8465203

D. -parsons, S. Jones, X. Zhang, and J. Cheng-ho-lin, An Integrated Genomic Analysis of Human Glioblastoma Multiforme, Science, vol.25, issue.13, p.1807, 2008.
DOI : 10.1002/jcc.20084

T. Pedchenko, A. Gonzalez, D. Wang, R. Dubois, and P. Massion, Peroxisome Proliferator???Activated Receptor ??/?? Expression and Activation in Lung Cancer, American Journal of Respiratory Cell and Molecular Biology, vol.39, issue.6, pp.689-696, 2008.
DOI : 10.1016/j.cellsig.2005.07.009

E. -pestereva, S. Kanakasabai, and J. Bright, PPAR?? agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells, British Journal of Cancer, vol.63, issue.10, pp.1702-1714, 2012.
DOI : 10.1126/science.1151526

J. Peters, H. Hollingshead, and F. Gonzalez, Role of peroxisome-proliferator-activated receptor ??/?? (PPAR??/??) in gastrointestinal tract function and disease, Clinical Science, vol.115, issue.4, pp.107-127, 2008.
DOI : 10.1042/CS20080022

J. Peters and F. Gonzalez, Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta ({PPARbeta/delta)} in cell proliferation and cancer, pp.230-241, 2009.

J. Peters, J. Foreman, and F. Gonzalez, Dissecting the role of peroxisome proliferator-activated receptor-??/?? (PPAR??/??) in colon, breast, and lung carcinogenesis, Cancer and Metastasis Reviews, vol.512, issue.7, pp.619-659, 2011.
DOI : 10.1007/978-1-60327-530-9_16

J. Peters, Y. Shah, and F. Gonzalez, The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention, Nature Reviews Cancer, vol.74, issue.3, pp.181-95, 2012.
DOI : 10.1016/j.cardiores.2007.01.010

L. Piqueras, A. Reynolds, K. Hodivala-dilke, A. Alfranca, J. Redondo et al., Activation of PPAR??/?? Induces Endothelial Cell Proliferation and Angiogenesis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.27, issue.1, pp.63-72, 2007.
DOI : 10.1161/01.ATV.0000250972.83623.61

G. -polekhina, C. House, N. Traficante, J. Mackay, F. Relaix et al., Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-?? signaling, Nature Structural Biology, vol.9, issue.1, pp.68-75, 2002.
DOI : 10.1038/nsb743

J. -qi, M. Pellecchia, and A. R. Ze-'ev, The Siah2-HIF-FoxA2 axis in prostate cancer? new markers and therapeutic opportunities, Oncotarget, vol.1, p.379, 2010.

-. , J. Ely, and K. , Degrading liaisons: Siah structure revealed, Nat Struct Biol, vol.9, pp.8-10, 2002.

M. -ricote and C. Glass, PPARs and molecular mechanisms of transrepression, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1771, issue.8, pp.926-961, 2007.
DOI : 10.1016/j.bbalip.2007.02.013

M. -ricote, A. Li, T. Willson, C. Kelly, and C. Glass, The peroxisome proliferator-activated receptor-?? is a negative regulator of macrophage activation, Nature, vol.16, issue.6662, pp.79-82, 1998.
DOI : 10.1128/MCB.16.9.4808

U. -risérus, D. Sprecher, T. Johnson, E. Olson, S. Hirschberg et al., Activation of Peroxisome Proliferator-Activated Receptor (PPAR)?? Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men, Diabetes, vol.57, issue.2, pp.332-371, 2008.
DOI : 10.2337/db07-1318

H. -ro, Y. Jang, and M. Rhee, The RING domain of Siaz, the zebrafish homologue of Drosophila seven in absentia, is essential for cellular growth arrest, Mol Cells, vol.17, pp.160-165, 2004.

H. -ro, K. Kim, T. Huh, S. Lee, and M. Rhee, Expression pattern of Siaz gene during the zebrafish embryonic development, Gene Expression Patterns, vol.3, issue.4, pp.483-491, 2003.
DOI : 10.1016/S1567-133X(03)00061-9

D. -robyr, A. Wolffe, and W. Wahli, Nuclear Hormone Receptor Coregulators In Action: Diversity For Shared Tasks, Molecular Endocrinology, vol.14, issue.3, pp.329-376, 2000.
DOI : 10.1210/mend.14.3.0411

R. -roeder, Transcriptional regulation and the role of diverse coactivators in animal cells, FEBS Letters, vol.5, issue.4, pp.909-924, 2005.
DOI : 10.1038/nrg1471

M. -roh, S. Hong, J. Jeong, H. Kwon, M. Kim et al., Gene Expression Profiling of Breast Cancers with Emphasis of ??-Catenin Regulation, Journal of Korean Medical Science, vol.19, issue.2, pp.275-82, 2004.
DOI : 10.3346/jkms.2004.19.2.275

J. -roperch, F. Lethrone, S. Prieur, L. Piouffre, D. Israeli et al., SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: Identification of common effectors with p53 and p21Waf1, Proceedings of the National Academy of Sciences, vol.15, issue.17, pp.8070-8073, 1999.
DOI : 10.1038/387299a0

I. Saluja, J. Granneman, and R. Skoff, PPAR ? agonists stimulate oligodendrocyte differentiation in tissue culture, Glia, vol.270, issue.3, pp.191-204, 2001.
DOI : 10.1128/MCB.15.1.351

A. -saurin, K. Borden, M. Boddy, and P. Freemont, Does this have a familiar RING?, Trends in Biochemical Sciences, vol.21, issue.6, pp.208-222, 1996.
DOI : 10.1016/S0968-0004(96)80017-X

R. Schmidt, C. Park, A. Ahmed, J. Gundelach, N. Reed et al., Inhibition of RAS-Mediated Transformation and Tumorigenesis by Targeting the Downstream E3 Ubiquitin Ligase Seven in Absentia Homologue, Cancer Research, vol.67, issue.24, pp.11798-11810, 2007.
DOI : 10.1158/0008-5472.CAN-06-4471

J. Schwartzbaum, F. Jonsson, A. Ahlbom, S. Preston-martin, S. Lonn et al., Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk, International Journal of Cancer, vol.1, issue.3, pp.423-431, 2003.
DOI : 10.1097/00130832-200110000-00006

E. -seree, P. Villard, J. Pascussi, T. Pineau, P. Maurel et al., Evidence for a new human CYP1A1 regulation pathway involving PPAR-?? and 2 PPRE sites, Gastroenterology, vol.127, issue.5, pp.1436-1481, 2004.
DOI : 10.1053/j.gastro.2004.08.023

A. Shmueli and M. Oren, Life, Death, and Ubiquitin: Taming the Mule, Cell, vol.121, issue.7, pp.963-968, 2005.
DOI : 10.1016/j.cell.2005.06.018

N. Simonavicius, D. Robertson, D. Bax, C. Jones, I. Huijbers et al., Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma, Modern Pathology, vol.111, issue.3, pp.308-323, 2008.
DOI : 10.1007/BF00230490

D. Sprecher, C. Massien, G. Pearce, A. Billin, I. Perlstein et al., Triglyceride:High-Density Lipoprotein Cholesterol Effects in Healthy Subjects Administered a Peroxisome Proliferator Activated Receptor ?? Agonist, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.27, issue.2, pp.359-65, 2007.
DOI : 10.1161/01.ATV.0000252790.70572.0c

R. Stephen, M. Gustafsson, M. Jarvis, R. Tatoud, B. Marshall et al., Activation of Peroxisome Proliferator-Activated Receptor ?? Stimulates the Proliferation of Human Breast and Prostate Cancer Cell Lines, Cancer Research, vol.64, issue.9, pp.3162-70, 2004.
DOI : 10.1158/0008-5472.CAN-03-2760

R. Stupp, M. Hegi, M. Gilbert, and A. Chakravarti, Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions, Journal of Clinical Oncology, vol.25, issue.26, pp.4127-4163, 2007.
DOI : 10.1200/JCO.2007.11.8554

R. Stupp, M. Hegi, W. Mason, M. Van-den-bent, M. Taphoorn et al., Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-66, 2009.
DOI : 10.1016/S1470-2045(09)70025-7

L. Sun and Z. Chen, The novel functions of ubiquitination in signaling, Current Opinion in Cell Biology, vol.16, issue.2, pp.119-145, 2004.
DOI : 10.1016/j.ceb.2004.02.005

L. Susini, B. Passer, N. Amzallag-elbaz, T. Juven-gershon, S. Prieur et al., Siah-1 binds and regulates the function of Numb, Proceedings of the National Academy of Sciences, vol.92, issue.14, pp.15067-72, 2001.
DOI : 10.1073/pnas.92.14.6414

O. -takayama, H. Yamamoto, B. Damdinsuren, Y. Sugita, C. Ngan et al., Expression of PPAR?? in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology, British Journal of Cancer, vol.32, issue.7, pp.889-895, 2006.
DOI : 10.1016/j.ejso.2005.11.005

A. -telerman and R. Amson, The molecular programme of tumour reversion: the steps beyond malignant transformation, Nature Reviews Cancer, vol.101, issue.3, pp.206-222, 2009.
DOI : 10.4049/jimmunol.166.11.6545

B. Tong, J. Tan, L. Tajeda, S. Das, J. Chapman et al., Heightened Expression of Cyclooxygenase-2 and Peroxisome Proliferator-Activated Receptor-?? in Human Endometrial Adenocarcinoma, Neoplasia, vol.2, issue.6, pp.483-490, 2000.
DOI : 10.1038/sj.neo.7900119

L. Topol, X. Jiang, H. Choi, L. Garrett-beal, and P. Carolan, Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3???independent ??-catenin degradation, The Journal of Cell Biology, vol.125, issue.5, pp.899-908, 2003.
DOI : 10.1016/S1097-2765(00)80200-2

M. -tuynder, L. Susini, S. Prieur, S. Besse, G. Fiucci et al., Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1, Proceedings of the National Academy of Sciences, vol.276, issue.50, 2002.
DOI : 10.1074/jbc.M108954200

A. Varshavsky, The ubiquitin system, Trends in Biochemical Sciences, vol.22, issue.10, pp.383-390, 1997.
DOI : 10.1016/S0968-0004(97)01122-5

K. Wagner, M. Benchetrit, L. Bianchini, J. Michiels, and N. Wagner, Peroxisome proliferator-activated receptor ??/?? (PPAR??/??) is highly expressed in liposarcoma and promotes migration and proliferation, The Journal of Pathology, vol.22, issue.4, pp.575-588, 2011.
DOI : 10.1210/me.2007-0190

N. Wagner, C. Jehl-piétri, P. Lopez, J. Murdaca, C. Giordano et al., Peroxisome proliferator-activated receptor ?? stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin, Cardiovascular Research, vol.10, issue.1, pp.61-71, 2009.
DOI : 10.1038/nm1116

T. Wang, J. Xu, X. Yu, R. Yang, and Z. Han, Peroxisome proliferator-activated receptor ?? in malignant diseases, Critical Reviews in Oncology/Hematology, vol.58, issue.1, pp.1-14, 2006.
DOI : 10.1016/j.critrevonc.2005.08.011

M. Winter, D. Sombroek, I. Dauth, J. Moehlenbrink, K. Scheuermann et al., Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR, Nature Cell Biology, vol.63, issue.7, pp.812-836, 2008.
DOI : 10.1126/science.281.5383.1677

M. -xia, M. Hou, H. Zhu, J. Ma, Z. Tang et al., Anthocyanins Induce Cholesterol Efflux from Mouse Peritoneal Macrophages, Journal of Biological Chemistry, vol.15, issue.44, pp.36792-36801, 2005.
DOI : 10.1016/S1096-7192(02)00111-7

Q. -xie, H. Guo, G. Dallman, S. Fang, A. Weissman et al., SINAT5 promotes ubiquitin-related degradation of NAC1 to attenuate auxin signals, Nature, vol.11, issue.6903, pp.167-70, 2002.
DOI : 10.1046/j.1365-313X.1998.00343.x

J. -yan, M. Young, L. Cui, G. Lopaschuk, R. Liao et al., Increased Glucose Uptake and Oxidation in Mouse Hearts Prevent High Fatty Acid Oxidation but Cause Cardiac Dysfunction in Diet-Induced Obesity, Circulation, vol.119, issue.21, pp.2818-2846, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.832915

X. Yang, S. Kume, Y. Tanaka, K. Isshiki, S. Araki et al., GW501516, a PPAR?? Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NF??B Pathway in Mice, PLoS ONE, vol.120, issue.9, 2011.
DOI : 10.1371/journal.pone.0025271.t001

X. Yang, L. Wang, T. Chen, D. Hodge, J. Resau et al., Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT, 2000.

M. -yano, E. Imagawa, M. Tada, and T. Moriuchi, In silico and systematic molecular evolutionary analysis of human SIAH1b inactivation, Hokkaido Igaku Zasshi, vol.80, pp.201-210, 2005.

E. -yego and S. Mohr, siah-1 Protein Is Necessary for High Glucose-induced Glyceraldehyde-3-phosphate Dehydrogenase Nuclear Accumulation and Cell Death in M??ller Cells, Journal of Biological Chemistry, vol.156, issue.5, pp.3181-90, 2010.
DOI : 10.1016/S0002-9440(10)64970-X

Y. -yin, R. Russell, L. Dettin, R. Bai, Z. Wei et al., Peroxisome Proliferator-Activated Receptor ?? and ?? Agonists Differentially Alter Tumor Differentiation and Progression during Mammary Carcinogenesis, Cancer Research, vol.65, issue.9, pp.3950-3957, 2005.
DOI : 10.1158/0008-5472.CAN-04-3990

T. -yoshikawa, Z. Brkanac, B. Dupont, G. Xing, R. Leach et al., Assignment of the Human Nuclear Hormone Receptor, NUC1 (PPARD), to Chromosome 6p21.1???p21.2, Genomics, vol.35, issue.3, pp.637-645, 1996.
DOI : 10.1006/geno.1996.0417

J. -youssef and M. Badr, Peroxisome proliferator-activated receptors and cancer: challenges and opportunities, British Journal of Pharmacology, vol.14, issue.1, pp.68-82, 2011.
DOI : 10.3748/wjg.14.2168

J. Zhao, C. Wang, J. Wang, X. Yang, N. Diao et al., E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein, FEBS Letters, vol.76, issue.19, pp.2943-50, 2011.
DOI : 10.1128/JVI.76.13.6495-6501.2002

D. Louis, H. Ohgaki, O. Wiestler, W. Cavenee, P. Burger et al., The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007.
DOI : 10.1093/jnen/60.9.863

S. Tanaka, D. Louis, W. Curry, T. Batchelor, and J. Dietrich, Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?, Nature Reviews Clinical Oncology, vol.455, issue.1, pp.14-26, 2013.
DOI : 10.1038/nature07385

M. Heneka and G. Landreth, PPARs in the brain, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1771, issue.8, pp.1031-1076, 2007.
DOI : 10.1016/j.bbalip.2007.04.016

S. Kliewer, K. Umesono, D. Noonan, R. Heyman, and R. Evans, Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, Nature, vol.358, issue.6389, pp.771-774, 1992.
DOI : 10.1038/358771a0

J. Berger and D. Moller, The Mechanisms of Action of PPARs, Annual Review of Medicine, vol.53, issue.1, pp.409-435, 2002.
DOI : 10.1146/annurev.med.53.082901.104018

C. Wolfrum, C. Borrmann, T. Borchers, and F. Spener, Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors ??- and ??-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus, Proceedings of the National Academy of Sciences, vol.188, issue.1-2, pp.2323-2328, 2001.
DOI : 10.1023/A:1006883303023

G. Chinetti, J. Fruchart, and B. Staels, Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation, Inflammation Research, vol.49, issue.10, 2000.
DOI : 10.1007/s000110050622

A. Lefebvre, M. Laville, N. Vega, J. Riou, L. Van-gaal et al., Depot-Specific Differences in Adipose Tissue Gene Expression in Lean and Obese Subjects, Diabetes, vol.47, issue.1, pp.98-103, 1998.
DOI : 10.2337/diab.47.1.98

D. Panigrahy, A. Kaipainen, M. Kieran, and S. Huang, PPARs: A Double-Edged Sword in Cancer Therapy? PPAR Res, p.2350351, 2008.

L. Tatenhorst, E. Hahnen, and M. Heneka, Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors, PPAR Research, vol.7, issue.1, p.204514, 2008.
DOI : 10.1159/000120028

W. Chearwae and J. Bright, PPAR?? agonists inhibit growth and expansion of CD133+ brain tumour stem cells, British Journal of Cancer, vol.50, issue.12, pp.2044-2053, 2008.
DOI : 10.1046/j.1471-4159.2002.00899.x

J. Youssef and M. Badr, Peroxisome proliferator-activated receptors and cancer: challenges and opportunities, British Journal of Pharmacology, vol.14, issue.1, pp.68-82, 2011.
DOI : 10.3748/wjg.14.2168

L. Michalik, B. Desvergne, and W. Wahli, Peroxisome-proliferator-activated receptors and cancers: complex stories, Nature Reviews Cancer, vol.63, issue.1, pp.61-70, 2004.
DOI : 10.1172/JCI1235

D. Genini, R. Garcia-escudero, G. Carbone, and C. Catapano, Transcriptional and Non-Transcriptional Functions of PPAR??/?? in Non-Small Cell Lung Cancer, PLoS ONE, vol.7, issue.9, p.46009, 2012.
DOI : 10.1371/journal.pone.0046009.s004

B. Park, B. Vogelstein, and K. Kinzler, Genetic disruption of PPAR?? decreases the tumorigenicity of human colon cancer cells, Proceedings of the National Academy of Sciences, vol.260, issue.5104, pp.2598-2603, 2001.
DOI : 10.1126/science.8465203

R. Stephen, M. Gustafsson, M. Jarvis, R. Tatoud, B. Marshall et al., Activation of Peroxisome Proliferator-Activated Receptor ?? Stimulates the Proliferation of Human Breast and Prostate Cancer Cell Lines, Cancer Research, vol.64, issue.9, pp.3162-3170, 2004.
DOI : 10.1158/0008-5472.CAN-03-2760

A. Brauckhoff, M. Malz, D. Tschaharganeh, N. Malek, A. Weber et al., Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells, Journal of Hepatology, vol.55, issue.5, pp.1049-1057, 2011.
DOI : 10.1016/j.jhep.2011.02.019

R. Carthew and G. Rubin, seven in absentia, a gene required for specification of R7 cell fate in the Drosophila eye, Cell, vol.63, issue.3, pp.561-577, 1990.
DOI : 10.1016/0092-8674(90)90452-K

D. Hoeller, C. Hecker, and I. Dikic, Ubiquitin and ubiquitin-like proteins in cancer pathogenesis, Nature Reviews Cancer, vol.279, issue.10, pp.776-788, 2006.
DOI : 10.4161/cc.4.4.1588

G. Polekhina, C. House, N. Traficante, J. Mackay, F. Relaix et al., Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-?? signaling, Nature Structural Biology, vol.9, issue.1, pp.68-75, 2002.
DOI : 10.1038/nsb743

A. Germani, H. Bruzzoni-giovanelli, A. Fellous, S. Gisselbrecht, N. Varin-blank et al., SIAH-1 interacts with ??-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis, Oncogene, vol.19, issue.52, pp.5997-6006, 2000.
DOI : 10.1101/gad.12.12.1775

E. Santelli, M. Leone, C. Li, T. Fukushima, N. Preece et al., Structural Analysis of Siah1-Siah-interacting Protein Interactions and Insights into the Assembly of an E3 Ligase Multiprotein Complex, Journal of Biological Chemistry, vol.19, issue.40, pp.34278-34287, 2005.
DOI : 10.1128/MCB.19.1.724

G. Hu, S. Zhang, M. Vidal, J. Baer, T. Xu et al., Mammalian homologs of seven in absentia regulate DCC via the ubiquitin-proteasome??pathway, Genes & Development, vol.11, issue.20, pp.2701-2714, 1997.
DOI : 10.1101/gad.11.20.2701

J. Zhang, M. Guenther, R. Carthew, and M. Lazar, Proteasomal regulation of nuclear receptor corepressor-mediated??repression, Genes & Development, vol.12, issue.12, pp.1775-1780, 1998.
DOI : 10.1101/gad.12.12.1775

S. Johnsen, M. Subramaniam, D. Monroe, R. Janknecht, and T. Spelsberg, Modulation of Transforming Growth Factor ?? (TGF??)/Smad Transcriptional Responses through Targeted Degradation of TGF??-inducible Early Gene-1 by Human Seven in Absentia Homologue, Journal of Biological Chemistry, vol.11, issue.34, pp.30754-30759, 2002.
DOI : 10.1074/jbc.M105895200

H. Habelhah, I. Frew, A. Laine, P. Janes, F. Relaix et al., Stress-induced decrease in TRAF2 stability is mediated by Siah2, The EMBO Journal, vol.21, issue.21, pp.5756-5765, 2002.
DOI : 10.1093/emboj/cdf576

J. Tanikawa, E. Ichikawa-iwata, C. Kanei-ishii, A. Nakai, S. Matsuzawa et al., p53 Suppresses the c-Myb-induced Activation of Heat Shock Transcription Factor 3, Journal of Biological Chemistry, vol.13, issue.20, pp.15578-15585, 2000.
DOI : 10.1016/S0092-8674(00)81401-4

G. Gutierrez, A. Vögtlin, A. Castro, I. Ferby, G. Salvagiotto et al., Meiotic regulation of the CDK activator RINGO/Speedy by ubiquitin-proteasome-mediated processing and degradation, Nature Cell Biology, vol.37, issue.10, pp.1084-1094, 2006.
DOI : 10.1016/0092-8674(84)90409-4

J. Famulski, N. Trivedi, D. Howell, Y. Yang, Y. Tong et al., Siah Regulation of Pard3A Controls Neuronal Cell Adhesion During Germinal Zone Exit, Science, vol.185, issue.1-3, pp.1834-1838, 2010.
DOI : 10.1159/000101298

C. Wong and A. Möller, Siah: A Promising Anticancer Target, Cancer Research, vol.73, issue.8, pp.2400-2406, 2013.
DOI : 10.1158/0008-5472.CAN-12-4348

A. Iwai, H. Marusawa, S. Matsuzawa, T. Fukushima, M. Hijikata et al., Siah-1L, a novel transcript variant belonging to the human Siah family of proteins, regulates ??-catenin activity in a p53-dependent manner, Oncogene, vol.23, issue.45, pp.7593-7600, 2004.
DOI : 10.1006/bbrc.2001.4788

G. Fiucci, S. Beaucourt, D. Duflaut, A. Lespagnol, P. Stumptner-cuvelette et al., Siah-1b is a direct transcriptional target of p53: Identification of the functional p53 responsive element in the siah-1b promoter, Proceedings of the National Academy of Sciences, vol.512, issue.1-3, pp.3510-3515, 2004.
DOI : 10.1016/S0014-5793(02)02265-2

D. Louvard, H. Reggio, and G. Warren, Antibodies to the Golgi complex and the rough endoplasmic reticulum, The Journal of Cell Biology, vol.92, issue.1, pp.92-107, 1982.
DOI : 10.1083/jcb.92.1.92

R. Stephen, M. Gustafsson, M. Jarvis, R. Tatoud, B. Marshall et al., Activation of Peroxisome Proliferator-Activated Receptor ?? Stimulates the Proliferation of Human Breast and Prostate Cancer Cell Lines, Cancer Research, vol.64, issue.9, pp.3162-3170, 2004.
DOI : 10.1158/0008-5472.CAN-03-2760

K. Wagner, M. Benchetrit, L. Bianchini, J. Michiels, and N. Wagner, Peroxisome proliferator-activated receptor ??/?? (PPAR??/??) is highly expressed in liposarcoma and promotes migration and proliferation, The Journal of Pathology, vol.22, issue.4, pp.575-588, 2011.
DOI : 10.1210/me.2007-0190

M. Hara, N. Agrawal, S. Kim, M. Cascio, M. Fujimuro et al., S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding, Nature Cell Biology, vol.92, issue.7, pp.665-674, 2005.
DOI : 10.1073/pnas.92.16.7162

Y. Nagano, T. Fukushima, K. Okemoto, K. Tanaka, D. Bowtell et al., stability and cell migration under metabolic stress, Cell Cycle, vol.1, issue.15, pp.2592-2602, 2011.
DOI : 10.1126/science.1092053

R. Gupta, J. Tan, W. Krause, M. Geraci, T. Willson et al., Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer, Proceedings of the National Academy of Sciences, vol.20, issue.11, pp.13275-13280, 2000.
DOI : 10.1093/carcin/20.11.2045

B. Tong, J. Tan, L. Tajeda, S. Das, J. Chapman et al., Heightened Expression of Cyclooxygenase-2 and Peroxisome Proliferator-Activated Receptor-?? in Human Endometrial Adenocarcinoma, Neoplasia, vol.2, issue.6, pp.483-490, 2000.
DOI : 10.1038/sj.neo.7900119

J. Reed and K. Ely, Degrading liaisons: Siah structure revealed, Nature Structural Biology, vol.9, issue.1, pp.8-10, 2002.
DOI : 10.1038/nsb0102-8

H. He, E. Fokas, A. You, R. Engenhart-cabillic, and H. An, Siah1 proteins enhance radiosensitivity of human breast cancer cells, BMC Cancer, vol.160, issue.3, p.403, 2010.
DOI : 10.1667/RR3043

A. Papi, L. Tatenhorst, D. Terwel, M. Hermes, M. Kummer et al., glioma models, Journal of Neurochemistry, vol.37, issue.6, pp.1779-1790, 2009.
DOI : 10.1016/j.febslet.2007.11.081

N. Krieger-hinck, U. Schumacher, A. Müller, and U. Valentiner, The Effect of the PPAR-?? Agonist Rosiglitazone on Neuroblastoma SK-N-SH Cells in a Metastatic Xenograft Mouse Model, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, vol.18, issue.8, pp.387-393, 2010.
DOI : 10.3727/096504010X12644422320708

J. Zhao, C. Wang, J. Wang, X. Yang, N. Diao et al., E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein, FEBS Letters, vol.76, issue.19, pp.943-50, 2011.
DOI : 10.1128/JVI.76.13.6495-6501.2002

L. Barré, N. Venkatesan, J. Magdalou, P. Netter, S. Fournel-gigleux et al., Evidence of calcium-dependent pathway in the regulation of human ??1,3-glucuronosyltransferase-1 (GlcAT-I) gene expression: a key enzyme in proteoglycan synthesis, The FASEB Journal, vol.20, issue.10, pp.1692-1696, 2006.
DOI : 10.1002/jcb.20189

D. Singh, B. Bhargavan, B. Chhunchha, E. Kubo, A. Kumar et al., Transcriptional Protein Sp1 Regulates LEDGF Transcription by Directly Interacting with Its Cis-Elements in GC-Rich Region of TATA-Less Gene Promoter, PLoS ONE, vol.202, issue.5, p.37012, 2012.
DOI : 10.1371/journal.pone.0037012.s001

A. Möller, C. House, C. Wong, D. Scanlon, M. Liu et al., Inhibition of Siah ubiquitin ligase function, Oncogene, vol.12, issue.2, pp.289-296, 2009.
DOI : 10.1152/physrev.00027.2001

R. Schmidt, C. Park, A. Ahmed, J. Gundelach, N. Reed et al., Inhibition of RAS-Mediated Transformation and Tumorigenesis by Targeting the Downstream E3 Ubiquitin Ligase Seven in Absentia Homologue, Cancer Research, vol.67, issue.24, pp.11798-11810, 2007.
DOI : 10.1158/0008-5472.CAN-06-4471